Sourced from:Direct from Manufacturer
Quick Summary
SymCarbo 150 Injection
Last updated on 26 Sep 2026 | 08:41 AM (IST)
₹750
MRP: ₹928.12
(You Save ₹178.12)
1 VIAL(s)
Sourced from:Direct from Manufacturer
19% OFF
₹750
MRP: ₹928.12
Inclusive of all taxes
19% Off
Dispatch: Today
Care delivered without the wait. Your order is prioritized for rapid dispatch to ensure it reaches your doorstep on time.
Substitutes
Kemocarb 150mg Injection
FRESENIUS KABI ...
₹ 1256.00/injection
68% costlier
Carbomax 150mg Injection
GLS PHARMA LTD
₹ 615.00/injection
18% cheaper
Carboteen 150mg Injection
VHB LIFE SCIENC...
₹ 656.00/injection
12% cheaper
Acoticyt 150mg Injection
ACCORD PHARMA
₹ 659.00/injection
12% cheaper
Better Service Satisfied Customers
Introduction
SymCarbo 150 Injection contains Carboplatin, an anti-cancer medicine belonging to the class of alkylating agents. It is used in the treatment of ovarian cancer and lung cancer, either alone or in combination with other chemotherapy medicines.
Carbowemb works by stopping the growth of cancer cells by interfering with their DNA replication. It is administered as an intravenous infusion under the supervision of a healthcare professional. Your oncologist will determine the exact dose and duration based on your condition, overall health, and treatment response.
This medicine can affect fertility in both men and women, either temporarily or permanently. It's important to discuss fertility preservation options before starting treatment. Women of childbearing age must use effective contraception during treatment and for at least six months after the last dose.
Uses
-
Ovarian cancer
-
Lung cancer (especially small cell lung cancer)
How SymCarbo 150 Injection Works
SymCarbo 150 Injection is a platinum-based chemotherapy drug. It works by damaging the DNA of cancer cells, which stops them from dividing and multiplying. This leads to cell death, helping to shrink the tumour and control the spread of cancer.
Interaction of SymCarbo 150 Injection with other drugs
Inform your doctor if you are taking:
-
Cisplatin or other chemotherapy drugs
-
Growth factors (e.g. Pegfilgrastim, Sargramostim, Molgramostim) – may suppress bone marrow function
-
Natalizumab – may increase the risk of infections
-
Vaccines, especially live ones – avoid unless advised
Storage conditions
-
Store below 25°C, away from light and metal surfaces.
-
Do not refrigerate or freeze.
-
Keep away from children and pets.
-
Dispose of unused medicine as per hospital or pharmacy guidance.
How to Use SymCarbo 150 Injection
SymCarbo 150 Injection is given as a slow intravenous infusion (drip) in a hospital or clinical setting. It should not be self-administered. Your doctor will schedule treatment cycles, and doses may vary depending on your response, body weight, and lab test results. If you miss an appointment, contact your doctor immediately.
Safety Advices
Pregnancy
SymCarbo 150 Injection is unsafe to use during pregnancy as it may cause harmful effects on the unborn baby. Report to your doctor if you are pregnant or think you may be pregnant, or planning for the pregnancy before starting the treatment.
Breast Feeding
Taking SymCarbo 150 Injection while breastfeeding may be unsafe because it may affect the child. Therefore, talk with your doctor to get more information.
Lungs
Consult your doctor if you experience any symptoms like; shortness of breath or lung tissue inflammation, or lung infection while taking a SymCarbo 150 Injection.
Liver
Consult your doctor if you experience any liver disease while taking this treatment. Patients with liver disease should cautiously use SymCarbo 150 Injection.
Alcohol
It is unknown whether consuming alcohol while taking a SymCarbo 150 Injection is safe. Please speak with your physician.
Driving
While taking SymCarbo 150 Injection, it is unsafe to drive or use machines because it may cause nausea, changes in vision, vomiting, etc. Talk to your doctor for more information.
Side Effects
Side effects are unwanted symptoms caused by medicines. Even though all medicines cause side effects, not everyone gets them.
Serious Side Effects
-
Low red blood cells (anemia)
-
Low white blood cells (neutropenia)
-
Low platelet count (risk of bleeding)
-
Allergic reactions (rash, itching, trouble breathing)
-
Kidney problems
-
Hearing loss
-
Lung inflammation (pneumonitis)
Common Side Effects
-
Nausea and vomiting
-
Fatigue and weakness
-
Hair loss
-
Mouth ulcers
-
Skin rashes or itchiness
-
Tingling or numbness in hands and feet (neuropathy)
-
Diarrhea or constipation
-
Loss of taste
-
Increased liver enzymes
If any side effect becomes severe or persistent, contact your doctor right away.
Expert Tips
-
Avoid planning pregnancy during and for 6 months after treatment. Use effective contraception.
-
Stay hydrated and eat small frequent meals to manage nausea.
-
Report symptoms like bleeding, infections, or breathing difficulty immediately.
-
Avoid live vaccines such as yellow fever during treatment unless approved by your doctor.
-
Talk about fertility options with your doctor before starting chemotherapy if planning for children.
FAQs
Q1.
What If I get pregnant while taking SymCarbo 150 Injection?
Consult your doctor if you are pregnant or think you may be pregnant before starting with SymCarbo 150 Injection intravenous infusion.
Q2.
Can SymCarbo 150 Injection be self-administered?
No, SymCarbo 150 Injection should not be self-administered and must be given only under the supervision of a healthcare professional.
Q3.
Should I use contraception even after the treatment with SymCarbo 150 Injection?
Yes, Using contraception during and after treatment with SymCarbo 150 Injection for at least six months is necessary.
Q4.
Can SymCarbo 150 Injection affect infertility?
Yes, SymCarbo 150 Injection may reduce fertility temporarily or permanently in both men and women. So, talk with your doctor about fertility concerns.
Q5.
Is it okay to take new medication while taking SymCarbo 150 Injection?
Do not take any medication during and after treatment with SymCarbo 150 Injection without informing your doctor.
Fact Box
|
Molecule name |
Carboplatin |
|
Therapeutic class |
Anti-cancer |
|
Pharmacological class |
Alkylating agent |
|
Indication |
Treatment for certain types of lung and ovarian cancer |
References
-
Hospira UK Limited, Electronic medicines compendium (EMC), [Revised on Oct 2021], [Accessed on 22nd Feb 2023],https://www.medicines.org.uk/emc/files/pil.3787.pdf
-
Teva Parenteral Medicines, Inc, U.S Food & Drug Administration FDA, [Revised on Oct 2011,[Accessed on 22nd Feb 2023], https://www.accessdata.fda.gov/drugsatfda_docs/label/2012/077139Orig1s016lbl.pdf
-
Wim J. F. van der Vijgh et.al; Clinical Pharmacokinetics of Carboplatin; [Published online on 09 Nov 2012];[Accessed on 22nd Feb 2023]; https://link.springer.com/article/10.2165/00003088-199121040-00002
Disclaimer
MrMed’s primary intention is to ensure that its consumers get information that is reviewed by experts, accurate and trustworthy. The information and contents of this website are for informational purposes only. They are not intended to be a substitute for professional medical advice, diagnosis, or treatment. Please seek the advice of your doctor and discuss all your queries related to any disease or medicine. Do not disregard professional medical advice or delay in seeking it because of something you have read on MrMed. Our mission is to support, not replace, the doctor-patient relationship.
Did you find this information helpful?
Author Details

Written By
Dr. Vikas B S
Pharm D

Reviewed By
Dr. Abhishaanth Prabu
MBBS
Last updated : 26 Sep 2026 | 08:41 AM (IST)

Want to know more?
Read Our Editorial Policy








